TYRA

Equibles Rating blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High

Market backdrop VIX 16.9 · calm Equity put/call 0.86

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +19%

above

Price vs 50-day avg +3%

above

RSI (14) 59

neutral

MACD trend Positive

52-week position 74%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +22%

trailing

6-month return +13%

trailing

YTD return +24%

this year

Relative strength +6%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $32 › 200d $27 — 50d above 200d

Institutional flow Distributing

2 of 163 funds reported for Jun 30 · net -1 sh shares

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

16.59% of float · ▲ +6.3% MoM · 9.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

163 holders — near 3-yr high, broad support

Squeeze score 89

high risk · 0–100

Fundamentals

Weak

EPS growth −33%

Y/Y

Free cash flow $-95.3M

Balance sheet $77.4M

net cash

Quant / Vol

risk profile

Very High

Volatility 61%

annualized · 1-yr

Max drawdown −35%

past year

ATR 5.8%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next

Next earnings call

Mar 5, 2027 Est · unconfirmed · in 34 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 13, 2026

Technicals

trend & momentum for long-term holders Buy

0 · 4 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+19% Bullish

Price vs 50-day avg

+3% Bullish

RSI (14)

59 Neutral

MACD trend

Positive Bullish

52-week position

74% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $32 › 200d $27 — 50d above 200d

Institutional flow Distributing

2 of 163 funds reported for Jun 30 · net -1 sh shares

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

16.59% of float · ▲ +6.3% MoM · 9.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

163 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $10 Now $33 · 74% 52-wk high $41

vs 200-day avg +19% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Cash, cash equivalents and marketable securities	$383.5M	Q1 2026	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
TYRA Tyra Biosciences, Inc. this stock	$1.96B	+23.9%	—	—	16.6%
ONC BeOne Medicines Ltd.	$437.67B	-0.6%	+22179.2%	890.7	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$126.01B	+9.9%	+46.2%	29.5	1.8%
REGN Regeneron Pharmaceuticals, Inc.	$70.03B	-14.0%	+20.8%	16.3	3.2%
ARGX Argenx SE	$56.84B	+8.8%	—	—	2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

163

% held: 111.3%
Reported: 2 of 163
Top holder: RA CAPITAL MANAGEMENT, L.…

Held Float

View

Held by Funds

Fund positions

170

View

Short & Settlement

Short Interest Rising

Shares short

9.9M

Days to cover: 9.2d
Change: +585.4K sh

View

Short Volume

Short vol %

60%

As of: Jul 9, 2026

Short Total

View

Fails to Deliver

FTD shares

467

Value: $11.9K
As of: Jun 12, 2026

View

Off-Exchange

Off-exchange %

54.7%

Week of: May 4, 2026

Off-exch Lit

View

Financials

Net income (FY)

$-119.9M

EPS diluted: $-2.01

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 2, 2026
This year: 9

View

Proposed Sales

Value

$2.0M

Shares: 53.2K
Filed: Mar 26, 2026

View

Exempt Offerings

Offering

$200.0M

Filed: Feb 13, 2024

View

Earnings & Events

Earnings Calls

Last call

Jun 3, 2026

View

Performance

	5D	20D	120D	MTD	YTD
TYRA	+2.0%	+21.8%	+13.1%	+2.0%	+23.9%
SPY	-0.2%	+0.8%	+7.4%	-0.2%	+9.3%
vs SPY	+2.2%	+20.9%	+5.6%	+2.2%	+14.6%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance